EVALUATION ON THE SAFETY OF TICAGRELOR AMONG INDIAN ACUTE CORONARY SYNDROME (ACS) PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2018, Vol 5, Issue 38
Abstract
BACKGROUND Ticagrelor is the novel class of anti-platelet drugs, has a simpler and faster metabolism (rapid onset of action), high potency and most importantly reversibility. The latter makes this drug safer in patients with bleeding complications. With this background, we studied the safety and tolerability of ticagrelor in Indian patients with acute coronary syndrome undergoing PCI. Primary Objective was to find out the assessment of bleeding events (major, minor or minimal) in acute coronary syndrome patients on Ticagrelor undergoing PCI. Secondary objective was to assess the incidence of dyspnea and other adverse events during 6- months follow up. MATERIALS AND METHODS This was single center, prospective, observational study involving 200 patients hospitalized in Medanta, The Medicity, Hospital, Gurgaon because of ACS undergoing PCI and were treated with Ticagrelor (180mg loading dose and 90mg thereafter) between December 2015 to May 2016. Study Design: Prospective Observational Study. RESULTS Total bleeding was observed in 29 (14.5%) patients, in which major bleeding was seen in 08 (4%) patients, minor bleeding was seen in 07 (3.5%) patients, minimal bleeding was observed in 13 (6.5%) patients, and fatal bleeding was seen in 01 (0.5%) patient Upper Gastro-Intestinal Bleeding (UGIB) was most commonly seen, followed by ecchymosis, lower gastrointestinal bleeding, haematuria, nasal bleeding, haemoptysis and intracranial haemorrhage. Dyspnea was observed in 39 (19.5%) patients among whom only 02 (1%) required discontinuation of study drug. CONCLUSION Study showed that Ticagrelor is a safe newer antiplatelet drug. Since chance of bleeding was significantly higher in females and diabetics, care should be taken in these patients with high risk for bleeding. Also, incidence of major bleeding and myocardial infarction was seen significantly less in our patients as compared to western counter parts. As our study was small observational study, these conclusions need to be confirmed with larger randomized trials in Indian patients.
Authors and Affiliations
Nabi Maknoo G. H. , Mayank Jain, Himanshu Dabral, Rajneesh Kapoor
Keywords
Related Articles
- EP ID EP572268
- DOI 10.18410/jebmh/2018/561
- Views 73
- Downloads 0
TO ASSESS THE EFFICACY OF MICRO NEEDLING THERAPY IN FACIAL ACNE SCARS
BACKGROUND Acne vulgaris is polymorphic inflammatory disease of the pilosebaceous follicle which occurs most commonly on the face and to a lesser extent on the back and chest. Scars may increase with loss of collagen. Pr...
PULSE OXIMETRY AS A POTENTIAL SCREENING TOOL FOR LOWER EXTREMITY ARTERIAL DISEASE IN ASYMPTOMATIC PATIENTS WITH DIABETES MELLITUS
BACKGROUND India, with a population greater than 1.1 billion, has the dubious distinction of having a larger number of people with diabetes than any other country in the world. It was estimated in the year. 2000 that the...
EVALUATION OF RESULTS IN FRACTURES OF BOTH BONES FOREARM TREATED WITH DYNAMIC COMPRESSION PLATING
BACKGROUND The anatomical alignment of the bones, the length, the radial bow, and axis should be restored for a good functional outcome. Conservative treatment has resulted in malunion, non-union, synostosis and ultimate...
A STUDY ON VARIATION OF INTRAOCULAR PRESSURE AND OCULAR PERFUSION PRESSURE OVER A 24-HOUR PERIOD
BACKGROUND Glaucoma is the second leading cause of blindness globally. Intraocular pressure and vascular risk factors have been proposed to be important risk factors in the development of glaucoma. The aim of this study...
STUDY OF ASSOCIATION OF PULMONARY TUBERCULOSIS AND DIABETES MELLITUS IN A TERTIARY CARE CENTRE
BACKGROUND Tuberculosis continues to be one of the most prevalent infection in the world despite all efforts to eliminate it. Patients with diabetes are more susceptible to infections as hyperglycaemia decreases the abil...